Home > Latest News > Accelerating technology for patient benefit in colorectal disease

Accelerating technology for patient benefit in colorectal disease

The event, entitled ‘Accelerating technology for patient benefit in colorectal disease’, will be held at the Royal Armouries in Leeds, in October – and brings together world leading speakers, scientists and engineers.

Following a successful regional launch in May, the NIHR Colorectal Therapies HTC is looking to expand its network and reach out to open-minded and innovative individuals and organisations to drive the development of new technologies for application in colorectal disease. The HTC will focus on three key areas for development in Colorectal Therapies: nanotechnology, biosensing and engineering. The HTC will stimulate blue-sky thinking to generate new ideas to be taken through concept development and evaluation, to funding and commercial partnerships. The HTC is currently working on projects with several SMEs in the Yorkshire region and wishes to expand its commercial links across the UK technology network.

The national event, which is free of charge, is open to broad-minded clinicians with a passion for advancing colorectal therapies, creative scientists and engineers wishing to apply or expand their expertise in this clinical area, industry partners involved in materials or device technologies, and patients with real-life experience of colorectal disease.

Plenary lectures will be delivered by high-profile speakers, including:

Sir Mark Welland, Head of the Nanoscience Centre, Department of Engineering at the University of Cambridge. Professor Welland has previously served as Chief Scientific Advisor in the UK Ministry of Defence and will be speaking about what technology has done to advance the medical sector and its future potential, with a specific focus on nanotechnology.

Dr Larry Nagahara, Director of the Office of Physical Sciences-Oncology and National Cancer Institute in the USA. He will be speaking about his experience of setting up centres in the US, similar to HTCs, for engaging physical scientists and clinicians to develop new technologies for the treatment of cancer.

Dr Richard Satava, Professor Emeritus of Surgery at the University of Washington Medical Centre and Senior Scientific Advisor to US Army Medical Research and Material Command (USAMRMC) is a pioneer in surgical robotics and telemedicine and will be speaking about future technological advancements in medicine, with a specific focus on surgical application.

Professor David Jayne, of the University of Leeds and Clinical Director of the NIHR Colorectal Therapies HTC said: “This meeting will bring together the best experts from engineering and science to apply their knowledge to areas of unmet clinical need identified by NHS clinicians and patients and the public. It will be a fascinating day leading to fruitful partnerships that will develop the next generation of innovative treatments for patients with colorectal disease.”